How do taxanes primarily affect cancer cells?

How do taxanes primarily affect cancer cells?

• A. By promoting DNA repair
• B. By inhibiting microtubule depolymerization
• C. By increasing blood flow to tumors
• D. By blocking tumor growth signals

Answer: (B)

Taxanes primarily affect cancer cells by inhibiting microtubule depolymerization. These agents, such as paclitaxel and docetaxel, work by stabilizing microtubules, which are critical components of the cell's cytoskeleton and are essential for proper cell division. When taxanes bind to microtubules, they prevent the normal breakdown of these structures, disrupting the mitotic spindle formation necessary for chromosome separation during cell division. This stabilization effectively halts the cell cycle, specifically during mitosis, leading to cell cycle arrest and ultimately, the death of cancer cells. By targeting microtubules, taxanes specifically exploit the differences in cellular behavior between rapidly dividing cancer cells and normal cells, which can help reduce the proliferation of tumors. Other options, such as promoting DNA repair, increasing blood flow to tumors, and blocking tumor growth signals, do not accurately describe the mechanism of action of taxanes. These methods delineate other therapeutic approaches or mechanisms but are not relevant to how taxanes exert their effects on cancer cells.

Taxanes primarily affect cancer cells by inhibiting microtubule depolymerization. These agents, such as paclitaxel and docetaxel, work by stabilizing microtubules, which are critical components of the cell's cytoskeleton and are essential for proper cell division. When taxanes bind to microtubules, they prevent the normal breakdown of these structures, disrupting the mitotic spindle formation necessary for chromosome separation during cell division.

This stabilization effectively halts the cell cycle, specifically during mitosis, leading to cell cycle arrest and ultimately, the death of cancer cells. By targeting microtubules, taxanes specifically exploit the differences in cellular behavior between rapidly dividing cancer cells and normal cells, which can help reduce the proliferation of tumors.

Other options, such as promoting DNA repair, increasing blood flow to tumors, and blocking tumor growth signals, do not accurately describe the mechanism of action of taxanes. These methods delineate other therapeutic approaches or mechanisms but are not relevant to how taxanes exert their effects on cancer cells.